Notably, blocking of the programmed cell death (PD) 1 receptor and its ligand, PD-L1, which respectively present increased expression levels on immune effector cells and MDSCs in MM patients, inhibited MDSC-mediated immune suppression. This evidence concerns the gene CD274 and Miyoshi myopathy.